Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 572 entries
Sorted by: Best Match Show Resources per page
JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin.

Journal of inflammation (London, England)

Park HJ, Lee HJ, Choi MS, Son DJ, Song HS, Song MJ, Lee JM, Han SB, Kim Y, Hong JT.
PMID: 18507870
J Inflamm (Lond). 2008 May 29;5:7. doi: 10.1186/1476-9255-5-7.

BACKGROUND: Bee venom therapy has been used to treat inflammatory diseases including rheumatoid arthritis in humans and in experimental animals. We previously found that bee venom and melittin (a major component of bee venom) have anti-inflammatory effect by reacting...

Cite
Park HJ, Lee HJ, Choi MS, et al. JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond). 2008;5:7doi: 10.1186/1476-9255-5-7.
Park, H. J., Lee, H. J., Choi, M. S., Son, D. J., Song, H. S., Song, M. J., Lee, J. M., Han, S. B., Kim, Y., & Hong, J. T. (2008). JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. Journal of inflammation (London, England), 57. https://doi.org/10.1186/1476-9255-5-7
Park, Hye Ji, et al. "JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin." Journal of inflammation (London, England) vol. 5 (2008): 7. doi: https://doi.org/10.1186/1476-9255-5-7
Park HJ, Lee HJ, Choi MS, Son DJ, Song HS, Song MJ, Lee JM, Han SB, Kim Y, Hong JT. JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond). 2008 May 29;5:7. doi: 10.1186/1476-9255-5-7. PMID: 18507870; PMCID: PMC2442592.
Copy Download .nbib Format: NLM
The use of vasodilators in the treatment of acute decompensated heart failure: novel versus conventional therapy.

Critical pathways in cardiology

Kirk JD, Diercks DB, Amsterdam EA.
PMID: 18340175
Crit Pathw Cardiol. 2004 Dec;3(4):216-20. doi: 10.1097/01.hpc.0000147143.29540.a5.

The majority of patients who present with acute decompensated heart failure require the addition of vasodilators to adequately reduce filling pressures and improve symptoms. Conventional therapies such as nitroglycerin and nitroprusside, although relatively effective, are difficult to use. Nesiritide,...

Cite
Kirk JD, Diercks DB, Amsterdam EA. The use of vasodilators in the treatment of acute decompensated heart failure: novel versus conventional therapy. Crit Pathw Cardiol. 2004;3(4):216-20doi: 10.1097/01.hpc.0000147143.29540.a5.
Kirk, J. D., Diercks, D. B., & Amsterdam, E. A. (2004). The use of vasodilators in the treatment of acute decompensated heart failure: novel versus conventional therapy. Critical pathways in cardiology, 3(4), 216-20. https://doi.org/10.1097/01.hpc.0000147143.29540.a5
Kirk, J Douglas, et al. "The use of vasodilators in the treatment of acute decompensated heart failure: novel versus conventional therapy." Critical pathways in cardiology vol. 3,4 (2004): 216-20. doi: https://doi.org/10.1097/01.hpc.0000147143.29540.a5
Kirk JD, Diercks DB, Amsterdam EA. The use of vasodilators in the treatment of acute decompensated heart failure: novel versus conventional therapy. Crit Pathw Cardiol. 2004 Dec;3(4):216-20. doi: 10.1097/01.hpc.0000147143.29540.a5. PMID: 18340175.
Copy Download .nbib Format: NLM
Microarray analysis of nitric oxide responsive transcripts in Arabidopsis.

Plant biotechnology journal

Parani M, Rudrabhatla S, Myers R, Weirich H, Smith B, Leaman DW, Goldman SL.
PMID: 17134397
Plant Biotechnol J. 2004 Jul;2(4):359-66. doi: 10.1111/j.1467-7652.2004.00085.x.

Nitric oxide (NO) is emerging as an important signalling molecule with diverse physiological functions in plants. In the current study, changes in gene expression in response to 0.1 mm and 1.0 mm sodium nitroprusside (SNP), a donor of NO,...

Cite
Parani M, Rudrabhatla S, Myers R, et al. Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant Biotechnol J. 2004;2(4):359-66doi: 10.1111/j.1467-7652.2004.00085.x.
Parani, M., Rudrabhatla, S., Myers, R., Weirich, H., Smith, B., Leaman, D. W., & Goldman, S. L. (2004). Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant biotechnology journal, 2(4), 359-66. https://doi.org/10.1111/j.1467-7652.2004.00085.x
Parani, Madasamy, et al. "Microarray analysis of nitric oxide responsive transcripts in Arabidopsis." Plant biotechnology journal vol. 2,4 (2004): 359-66. doi: https://doi.org/10.1111/j.1467-7652.2004.00085.x
Parani M, Rudrabhatla S, Myers R, Weirich H, Smith B, Leaman DW, Goldman SL. Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant Biotechnol J. 2004 Jul;2(4):359-66. doi: 10.1111/j.1467-7652.2004.00085.x. PMID: 17134397.
Copy Download .nbib Format: NLM
Hypertension in the critically ill patient.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine

Santhi R, Worthley LI.
PMID: 16573454
Crit Care Resusc. 2003 Mar;5(1):24-42.

OBJECTIVE: To review the management of persistent hypertension and hypertensive crisis in the critically ill patient.DATA SOURCES: A review of articles reported on hypertension and the critically ill patient.SUMMARY OF REVIEW: Hypertension is defined as a basal systolic blood...

Cite
Santhi R, Worthley LI. Hypertension in the critically ill patient. Crit Care Resusc. 2003;5(1):24-42
Santhi, R., & Worthley, L. I. (2003). Hypertension in the critically ill patient. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 5(1), 24-42.
Santhi, R, and Worthley, Lindsay I G. "Hypertension in the critically ill patient." Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine vol. 5,1 (2003): 24-42.
Santhi R, Worthley LI. Hypertension in the critically ill patient. Crit Care Resusc. 2003 Mar;5(1):24-42. PMID: 16573454.
Copy Download .nbib Format: NLM
Light-induced extinction originating from holographic scattering.

Optics letters

Imlau M, Woike T, Schaniel D, Schefer J, Fally M, Rupp RA.
PMID: 18033477
Opt Lett. 2002 Dec 15;27(24):2185-7. doi: 10.1364/ol.27.002185.

We present extinction spectra of sodium nitroprusside exhibiting holographic light scattering after irradiation with coherent light. A characteristic extinction band appearing in the vicinity of the wavelength of the pump beam was discovered as well as an increase of...

Cite
Imlau M, Woike T, Schaniel D, et al. Light-induced extinction originating from holographic scattering. Opt Lett. 2002;27(24):2185-7doi: 10.1364/ol.27.002185.
Imlau, M., Woike, T., Schaniel, D., Schefer, J., Fally, M., & Rupp, R. A. (2002). Light-induced extinction originating from holographic scattering. Optics letters, 27(24), 2185-7. https://doi.org/10.1364/ol.27.002185
Imlau, M, et al. "Light-induced extinction originating from holographic scattering." Optics letters vol. 27,24 (2002): 2185-7. doi: https://doi.org/10.1364/ol.27.002185
Imlau M, Woike T, Schaniel D, Schefer J, Fally M, Rupp RA. Light-induced extinction originating from holographic scattering. Opt Lett. 2002 Dec 15;27(24):2185-7. doi: 10.1364/ol.27.002185. PMID: 18033477.
Copy Download .nbib Format: NLM
A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection.

Talanta

Bloomfield MS.
PMID: 18968869
Talanta. 2002 Dec 06;58(6):1301-10. doi: 10.1016/s0039-9140(02)00421-6.

4-Aminophenol (4AP) is the primary degradation product of paracetamol which is limited at a low level (50 ppm or 0.005% w/w) in the drug substance by the European, United States, British and German Pharmacopoeias, employing a manual colourimetric limit...

Cite
Bloomfield MS. A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection. Talanta. 2002;58(6):1301-10doi: 10.1016/s0039-9140(02)00421-6.
Bloomfield, M. S. (2002). A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection. Talanta, 58(6), 1301-10. https://doi.org/10.1016/s0039-9140(02)00421-6
Bloomfield, M S. "A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection." Talanta vol. 58,6 (2002): 1301-10. doi: https://doi.org/10.1016/s0039-9140(02)00421-6
Bloomfield MS. A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection. Talanta. 2002 Dec 06;58(6):1301-10. doi: 10.1016/s0039-9140(02)00421-6. PMID: 18968869.
Copy Download .nbib Format: NLM
Determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate by titration with o-hydroxymercuribenzoate.

Talanta

Singh K, Fodeke BA.
PMID: 18963445
Talanta. 1983 Sep;30(9):693-4. doi: 10.1016/0039-9140(83)80158-1.

A direct titrimetric method has been developed for the determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate, by titration with o-hydroxymercuribenzoate, with sodium nitroprusside as indicator.

Cite
Singh K, Fodeke BA. Determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate by titration with o-hydroxymercuribenzoate. Talanta. 1983;30(9):693-4doi: 10.1016/0039-9140(83)80158-1.
Singh, K., & Fodeke, B. A. (1983). Determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate by titration with o-hydroxymercuribenzoate. Talanta, 30(9), 693-4. https://doi.org/10.1016/0039-9140(83)80158-1
Singh, K, and Fodeke, B A. "Determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate by titration with o-hydroxymercuribenzoate." Talanta vol. 30,9 (1983): 693-4. doi: https://doi.org/10.1016/0039-9140(83)80158-1
Singh K, Fodeke BA. Determination of thiocarbonate in the presence of sulphite, thiosulphate and thiocyanate by titration with o-hydroxymercuribenzoate. Talanta. 1983 Sep;30(9):693-4. doi: 10.1016/0039-9140(83)80158-1. PMID: 18963445.
Copy Download .nbib Format: NLM
A new crystal phase of barium nitroprusside trihydrate studied by neutron diffraction at 20 K.

Acta crystallographica. Section C, Crystal structure communications

Chevrier G, Kiat JM, Güida JA, Navaza A.
PMID: 15004353
Acta Crystallogr C. 2004 Mar;60:i27-i29. doi: 10.1107/S0108270104000599. Epub 2004 Feb 10.

The crystal of barium pentacyanonitrosylferrate trihydrate [barium nitroprusside trihydrate, Ba[Fe(CN)5(NO)] x 3H2O] has been studied by neutron diffraction at 20 K. The study was performed to characterize the structural phase generated by the phase transition undergone by the crystals...

Cite
Chevrier G, Kiat JM, Güida JA, et al. A new crystal phase of barium nitroprusside trihydrate studied by neutron diffraction at 20 K. Acta Crystallogr C. 2004;60:i27-i29doi: 10.1107/S0108270104000599.
Chevrier, G., Kiat, J. M., Güida, J. A., & Navaza, A. (2004). A new crystal phase of barium nitroprusside trihydrate studied by neutron diffraction at 20 K. Acta crystallographica. Section C, Crystal structure communications, 60i27-i29. https://doi.org/10.1107/S0108270104000599
Chevrier, G, et al. "A new crystal phase of barium nitroprusside trihydrate studied by neutron diffraction at 20 K." Acta crystallographica. Section C, Crystal structure communications vol. 60 (2004): i27-i29. doi: https://doi.org/10.1107/S0108270104000599
Chevrier G, Kiat JM, Güida JA, Navaza A. A new crystal phase of barium nitroprusside trihydrate studied by neutron diffraction at 20 K. Acta Crystallogr C. 2004 Mar;60:i27-i29. doi: 10.1107/S0108270104000599. Epub 2004 Feb 10. PMID: 15004353.
Copy Download .nbib Format: NLM
Differential effects of nitric oxide on rod and cone pathways in carp retina.

Science in China. Series C, Life sciences

Ye B, Du J, Yang X.
PMID: 18726301
Sci China C Life Sci. 1997 Feb;40(1):71-8. doi: 10.1007/BF02879109.

The effects of nitric oxide (NO) on electroretinograms and light responses of horizontal cells intracellularly recorded from isolated, superfused carp retinas were studied. Sodium nitroprusside (SNP), an NO donor, suppressed scotopic b wave, while enhancing photopic b wave, and...

Cite
Ye B, Du J, Yang X. Differential effects of nitric oxide on rod and cone pathways in carp retina. Sci China C Life Sci. 1997;40(1):71-8doi: 10.1007/BF02879109.
Ye, B., Du, J., & Yang, X. (1997). Differential effects of nitric oxide on rod and cone pathways in carp retina. Science in China. Series C, Life sciences, 40(1), 71-8. https://doi.org/10.1007/BF02879109
Ye, B, et al. "Differential effects of nitric oxide on rod and cone pathways in carp retina." Science in China. Series C, Life sciences vol. 40,1 (1997): 71-8. doi: https://doi.org/10.1007/BF02879109
Ye B, Du J, Yang X. Differential effects of nitric oxide on rod and cone pathways in carp retina. Sci China C Life Sci. 1997 Feb;40(1):71-8. doi: 10.1007/BF02879109. PMID: 18726301.
Copy Download .nbib Format: NLM
Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Neurotoxicity research

Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G.
PMID: 16787846
Neurotox Res. 2000;2(2):293-310. doi: 10.1007/BF03033799.

Brain undergoes neurodegeneration when excess free radicals overwhelm antioxidative defense systems during senescence, head trauma and/or neurotoxic insults. A site-specific accumulation of ferrous citrate-iron complexes in the substantia nigra dopaminergic neurons could lead to exaggerated dopamine turnover, dopamine auto-oxidation,...

Cite
Chiueh CC, Andoh T, Lai AR, et al. Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotox Res. 2000;2(2):293-310doi: 10.1007/BF03033799.
Chiueh, C. C., Andoh, T., Lai, A. R., Lai, E., & Krishna, G. (2000). Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotoxicity research, 2(2), 293-310. https://doi.org/10.1007/BF03033799
Chiueh, C C, et al. "Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals." Neurotoxicity research vol. 2,2 (2000): 293-310. doi: https://doi.org/10.1007/BF03033799
Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G. Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotox Res. 2000;2(2):293-310. doi: 10.1007/BF03033799. PMID: 16787846.
Copy Download .nbib Format: NLM
Purification of soluble guanylate cyclase from rat liver.

Proceedings of the National Academy of Sciences of the United States of America

Braughler JM, Mittal CK, Murad F.
PMID: 16592607
Proc Natl Acad Sci U S A. 1979 Jan;76(1):219-22. doi: 10.1073/pnas.76.1.219.

Soluble guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2] has been purified from rat liver and exhibited a single protein band on polyacrylamide gels coincident with activity and indicative of a molecular weight of 150,000. The apparent specific activity of...

Cite
Braughler JM, Mittal CK, Murad F. Purification of soluble guanylate cyclase from rat liver. Proc Natl Acad Sci U S A. 1979;76(1):219-22doi: 10.1073/pnas.76.1.219.
Braughler, J. M., Mittal, C. K., & Murad, F. (1979). Purification of soluble guanylate cyclase from rat liver. Proceedings of the National Academy of Sciences of the United States of America, 76(1), 219-22. https://doi.org/10.1073/pnas.76.1.219
Braughler, J M, et al. "Purification of soluble guanylate cyclase from rat liver." Proceedings of the National Academy of Sciences of the United States of America vol. 76,1 (1979): 219-22. doi: https://doi.org/10.1073/pnas.76.1.219
Braughler JM, Mittal CK, Murad F. Purification of soluble guanylate cyclase from rat liver. Proc Natl Acad Sci U S A. 1979 Jan;76(1):219-22. doi: 10.1073/pnas.76.1.219. PMID: 16592607; PMCID: PMC382909.
Copy Download .nbib Format: NLM
The effects of oxytocin on intracranial pressure.

Journal of neurosurgical anesthesiology

Thiagarajah S, Lear E, Azar I.
PMID: 15815422
J Neurosurg Anesthesiol. 1991 Dec;3(4):270-2. doi: 10.1097/00008506-199112000-00005.

The commonly used vasodilators sodium nitroprusside and nitroglycerine increase the intracranial pressure (ICP). Oxytocin is also a vasodilator although its primary effect is contraction of uterine smooth muscle. We therefore studied the effect of oxytocin on the ICP of...

Cite
Thiagarajah S, Lear E, Azar I. The effects of oxytocin on intracranial pressure. J Neurosurg Anesthesiol. 1991;3(4):270-2doi: 10.1097/00008506-199112000-00005.
Thiagarajah, S., Lear, E., & Azar, I. (1991). The effects of oxytocin on intracranial pressure. Journal of neurosurgical anesthesiology, 3(4), 270-2. https://doi.org/10.1097/00008506-199112000-00005
Thiagarajah, S, et al. "The effects of oxytocin on intracranial pressure." Journal of neurosurgical anesthesiology vol. 3,4 (1991): 270-2. doi: https://doi.org/10.1097/00008506-199112000-00005
Thiagarajah S, Lear E, Azar I. The effects of oxytocin on intracranial pressure. J Neurosurg Anesthesiol. 1991 Dec;3(4):270-2. doi: 10.1097/00008506-199112000-00005. PMID: 15815422.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 572 entries